Featuring the debunking of ‘fake news’, cardiovascular clinical trial controversy, open data in the USA, reduced lack of funding for preprint repositories, the wait for the launch of the Projekt DEAL and Wiley flagship journal, ranking and indices in science, and questions surrounding Plan S.
Featuring stakeholder opinions on the proposed White House Executive Order on open access in the USA, a new data-sharing declaration and the introduction of a financial incentive for publishing negative results in Germany
As the Open Pharma position statement reaches over 100 endorsements, we share why open access is important for public health and hear why publishing house Frontiers has endorsed the position statement.
Featuring a new database of journal policies, the launch of an open peer review trial in Nature, a summary of one patient advocate’s involvement in cancer research and the call from 21 Nobel laureates for an immediate open access mandate
Open Pharma Members, Supporters and key advisers came together to discuss how medical publication professionals can improve the accessibility and discoverability of scientific research.
Featuring the role of open science in combating the coronavirus outbreak, a new journal ranking system to measure research transparency and highlights from this week’s ISMPP U webinar.
Featuring a summary of a recent study on the compliance of clinical trial reporting under US law, the role of patients in medical publishing, the rising popularity of preprints and an overview of Open Pharma’s activities this week.
Featuring a summary of the updated ICMJE recommendations, the failure of the FDA and the NIH to enforce clinical trial reporting laws, an independent report aiming to improve the transparency of open access services, and the new article format coming to PLOS ONE
Featuring the current predictions for publishing trends in 2020, draft guidance on how to implement the DORA principles in research organizations and a new international observatory to tackle predatory publishers
Featuring Altmetric’s Christmas list, the current status of transformative agreements in relation to Plan S and a review of the ICMJE’s data sharing policy.